Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Screeners that run automatically... and then email you the results! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Twist Bioscience Corp (TWST)
Twist Bioscience Corp (TWST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 859,693
  • Shares Outstanding, K 56,858
  • Annual Sales, $ 203,570 K
  • Annual Income, $ -217,860 K
  • 60-Month Beta 1.22
  • Price/Sales 4.08
  • Price/Cash Flow N/A
  • Price/Book 1.11
Trade TWST with:

Options Overview Details

View History
  • Implied Volatility 96.08% ( +0.27%)
  • Historical Volatility 64.44%
  • IV Percentile 39%
  • IV Rank 34.78%
  • IV High 125.07% on 11/17/22
  • IV Low 80.62% on 02/17/23
  • Put/Call Vol Ratio 0.52
  • Today's Volume 41
  • Volume Avg (30-Day) 689
  • Put/Call OI Ratio 0.88
  • Today's Open Interest 8,565
  • Open Int (30-Day) 9,693

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/23
See More
  • Average Estimate -1.08
  • Number of Estimates 3
  • High Estimate -1.01
  • Low Estimate -1.12
  • Prior Year -1.24
  • Growth Rate Est. (year over year) +12.90%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.52 +1.45%
on 03/29/23
19.65 -25.04%
on 03/03/23
-4.73 (-24.31%)
since 02/28/23
3-Month
14.52 +1.45%
on 03/29/23
31.51 -53.25%
on 02/02/23
-7.19 (-32.80%)
since 12/28/22
52-Week
14.52 +1.45%
on 03/29/23
58.76 -74.93%
on 08/08/22
-32.32 (-68.69%)
since 03/28/22

Most Recent Stories

More News
DNA Data Storage Alliance Announces Board Appointments

The DNA Data Storage Alliance, a SNIA Technology Affiliate, formed in 2020 by Illumina, Inc. (NASDAQ: ILMN), Microsoft (Nasdaq: MSFT), Twist Bioscience Corporation (NASDAQ: TWST) and Western Digital...

ILMN : 225.26 (+1.45%)
MSFT : 284.05 (+1.26%)
TWST : 14.73 (-2.58%)
WDC : 37.28 (+1.86%)
TWIST ALERT: Bragar Eagel & Squire, P.C. is Investigating Twist Bioscience Corp on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Twist Bioscience Corp (NASDAQ: TWST) on behalf of long-term stockholders following...

TWST : 14.73 (-2.58%)
Twist Bioscience Announces Robust Antibody Discovery Services Integrating In Vivo, In Vitro and In Silico Approaches

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced an integrated offering...

TWST : 14.73 (-2.58%)
Twist Bioscience to Present at Upcoming Investor Conferences

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust,...

TWST : 14.73 (-2.58%)
Twist Bioscience (TWST) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

Twist Bioscience (TWST) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean...

TWST : 14.73 (-2.58%)
Twist Bioscience Publishes Data on VHH Single Domain Antibody Discovery Using New Methodology on Optofluidic Platform

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today published on the successful discovery...

TWST : 14.73 (-2.58%)
TWST FINAL DEADLINE TODAY: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Twist Bioscience Corporation Investors to Secure Counsel Before Important February 10 Deadline in Securities Class Action – TWST

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Twist Bioscience Corporation (NASDAQ: TWST) between December 13, 2019 and November 14, 2022, both dates...

TWST : 14.73 (-2.58%)
Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Twist Bioscience Corporation (TWST) Investors of Class Action and to Actively Participate

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Twist Bioscience Corporation ("Twist” or "the Company") (NASDAQ: TWST)...

TWST : 14.73 (-2.58%)
TWST SHAREHOLDER ALERT: Jakubowitz Law Reminds Twist Shareholders of a Lead Plaintiff Deadline of February 10, 2023

/PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Twist Bioscience Corporation...

TWST : 14.73 (-2.58%)
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Twist Bioscience Corporation (TWST)

The Law Offices of Frank R. Cruz reminds investors of the upcoming February 10, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Twist Bioscience...

TWST : 14.73 (-2.58%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Twist Bioscience Corporation operates as a biotechnology company. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development and DNA as a digital data storage medium. Twist Bioscience Corporation is headquartered...

See More

Key Turning Points

3rd Resistance Point 16.63
2nd Resistance Point 16.23
1st Resistance Point 15.48
Last Price 14.73
1st Support Level 14.34
2nd Support Level 13.94
3rd Support Level 13.19

See More

52-Week High 58.76
Fibonacci 61.8% 41.86
Fibonacci 50% 36.64
Fibonacci 38.2% 31.42
Last Price 14.73
52-Week Low 14.52

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar